Recent apparent changes to 340B drug pricing conditions by drug manufacturer Sanofi may eliminate 340B discounts for health centers using [...] …
Articles by : Tom Mirga, Editor at Large
A federal district judge has allowed five major drugmakers to file friend-of-the-court briefs in a lawsuit over patient eligibility to [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The proportion of retail contract pharmacies in the 340B program that contract exclusively with “core safety-net” facilities fell from 95% [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The U.S. Department of Health and Human Services (HHS) asked a federal court to deny a preliminary injunction sought by [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Drug manufacturer Pfizer is changing how healthcare providers access 340B pricing on two expensive, related heart medicines, effective Nov. 1, [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Eligible covered entities in Hawaii may enroll in the 340B program immediately rather than having to wait for the next [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
GlaxoSmithKline is sending 340B covered entities refunds for overcharges totaling $100 or more for purchases of two dosage forms of [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Congress should let for-profit hospitals into the 340B drug pricing program as “a long overdue evolutionary step” that will advance [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Drug makers AbbVie, Bristol Myers Squibb, Janssen, Lilly, and Merck asked a federal district court in South Carolina on Friday [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Senate Appropriators Urge HRSA to Penalize Drug Makers That Impose 340B Contract Pharmacy Conditions
Federal health care officials should use fines and “any available measures” to punish drug makers that deny 340B pricing for [...] …